Quantcast
Last updated on May 19, 2013 at 21:20 EDT

Latest Synthetic genomics Stories

2013-05-16 12:32:57

Program will now focus on utilizing SGI expertise in synthetic genomics to enhance algae LA JOLLA, Calif., May 16, 2013 /PRNewswire/ -- Synthetic Genomics Inc. (SGI), a privately held company dedicated to developing genomic-driven solutions to address global challenges, today announced a new co-funded research agreement with ExxonMobil to develop algae biofuels. The new agreement is a basic science research program that focuses on developing algal strains with significantly improved...

2013-03-27 12:23:15

Preeminent Scientist Will Receive Honor at Annual Dinner on Sept. 4, 2013. KANSAS CITY, Mo., March 27, 2013 /PRNewswire-USNewswire/ -- The MRIGlobal Board of Directors and Trustees today announced that it will present its annual Citation Award this year to J. Craig Venter, Ph.D., one of the leading scientists of the 21(st) century. Dr. Venter is the Founder, Chairman, and Chief Executive Officer of the J. Craig Venter Institute, a not-for-profit research organization dedicated to...

2012-09-17 10:23:36

LA JOLLA, Calif., Sept. 17, 2012 /PRNewswire/ -- Synthetic Genomics Inc. (SGI), a privately held company developing and commercializing genomic-driven solutions to solve a range of global challenges, today announced they have purchased from Febit Holding GmbH the worldwide rights to three families of patents and patent applications related to key synthetic genomic technologies. All related know-how, equipment and technical support for implementation, were also purchased. This...

2012-05-24 10:22:06

LA JOLLA, Calif., May 24, 2012 /PRNewswire/ -- Synthetic Genomics Inc. (SGI), a privately held company commercializing and developing genomic-driven solutions to solve a range of global challenges, today announced they have purchased an 81 acre site for scale up and testing of newly identified and engineered algal strains. The company will use the site, located in the Imperial Valley near the Salton Sea, to test algal strains isolated by SGI or developed through SGI's proprietary...

2012-03-26 13:38:10

Just as aspiring authors often read hundreds of books before starting their own, scientists are using decades of knowledge garnered from sequencing or "reading" the genetic codes of thousands of living things to now start writing new volumes in the library of life. J. Craig Venter, Ph.D., one of the most renowned of those scientists, described the construction of the first synthetic cell and many new applications of this work today at the 243rd National Meeting & Exposition of the...

2012-02-07 16:00:00

LA JOLLA, Calif. and IPSWICH, Mass., Feb. 7, 2012 /PRNewswire/ -- Synthetic Genomics, Inc. (SGI), a privately held company commercializing and developing genomic-driven solutions to solve a variety of global needs, and New England Biolabs, Inc. (NEB), today jointly announced that they have entered into a non-exclusive licensing agreement whereby NEB will commercialize the Gibson Assembly(TM) Master Mix. This product is based on the Gibson Assembly(TM) method which was developed by...

2012-02-07 16:00:00

IPSWICH, Mass. and LA JOLLA, Calif., Feb. 7, 2012 /PRNewswire/ -- New England Biolabs, Inc. (NEB) and Synthetic Genomics, Inc. (SGI) jointly announce that they have entered into a licensing agreement whereby NEB will introduce a master mix based on Gibson Assembly(TM), a revolutionary technology developed by Dr. Daniel Gibson and his colleagues at the J. Craig Venter Institute (JCVI) as part of a program sponsored by SGI. The financial details of this agreement were not...

2012-02-02 09:00:00

LA JOLLA, Calif. and CORALVILLE, Iowa, Feb. 2, 2012 /PRNewswire/ -- Synthetic Genomics, Inc. (SGI), a privately held company commercializing and developing genomic-driven solutions to solve a variety of global needs, and Integrated DNA Technologies, Inc. (IDT), the world leader in production and supply of oligonucleotides, today jointly announced that they have entered into an agreement to manufacture, market, and commercialize small synthetic gene products. The financial details of...

2012-01-17 12:00:00

LA JOLLA, Calif., Jan. 17, 2012 /PRNewswire/ -- Synthetic Genomics Inc. (SGI), a privately held company commercializing and developing genomic-driven solutions to solve a wide range of global challenges, today announced they have hired George E. Stagnitti as Vice President for Nutritional Products. Stagnitti is a proven leader with experience in developing sophisticated research programs and translating these into high value food and nutritional products for humans and animals. At SGI...